94310 ⎘
Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system; Nitrogen atoms attached in position 9
Sub-classes:COMPOUNDS FOR INHIBITING LY6K AND METHODS OF USING SAME
#2QUINACRINE AND DERIVATIVES THEREOF FOR TREATMENT OF VIRAL INFECTIONS
#3PERFLUORINATED AMIDE SALTS AND THEIR USES AS IONIC CONDUCTING MATERIALS
#4TETRASTYRENE-BASED COMPOUND AND APPLICATION THEREOF AND ELECTRONIC DEVICE USING THE SAME
#5BISAMINOQUINOLINES AND BISAMINOACRIDINES COMPOUNDS AND METHODS OF THEIR USE
#6Cholinesterase inhibitor polymorph and application thereof
#7Compounds for inhibiting LY6K and methods of using same
#8Autophagy inhibitors
#9Fused-tricyclic inhibitors of KRAS and methods of use thereof
#10CGAS in systemic lupus erythematosus (SLE)
#11Asymmetric bis-acridines with antitumour activity and their uses
#12HDMX inhibitors and their use for cancer treatment
#13Water soluble 4-azapodophyllotoxin analogs
#14Compounds for lnhibition of Unregulated Cell Growth
#15Autophagy Inhibitors
#16HISTONE DEACETYLASE INHIBITORS BASED ON DERIVATIVES OF TRICYCLIC POLYHYDROACRIDINE AND ANALOGS POSSESSING FUSED SATURATED FIVE-AND-SEVEN-MEMBERED RINGS
#17Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
#18Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
#19Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
#20IDENTIFICATION AND USE OF COMPOUNDS THAT AFFECT THE FIDELITY OF EUKARYOTIC TRANSLATION INITIATION CODON SELECTION
#21Compositions and methods for treating cancer
#22Targeted delivery and prodrug designs for platinum-acridine anti-cancer compounds and methods thereof
#23Autophagy inhibitors
#24Phenyl N-mustard linked to DNA-affinic molecules or water-soluble aryl rings, method and their use as cancer therapeutic agents
#251,2,3,4,5 6,7,8-octohydro-9-phenylacetamidoacridine, the preparation method and medical use thereof
#26Methods of facilitating neural cell survival using GDNF family ligand (GFL) mimetics or RET signaling pathway activators
#279-AMINOACRIDINE DERIVATIVES, THEIR PREPARATION AND USES
#28Compositions and methods for treating cancer
#29Method and compositions for treating amyloid-related diseases
#30Identification and use of compounds that affect the fidelity of eukaryotic translation initiation codon selection
#31NPY Y5 ANTAGONIST
#32NPY Y5 antagonist
#33Amine derivative having NPY Y5 receptor antagonistic activity
#34Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
#35Amine derivative having NPY Y5 receptor antagonistic activity
#36NOVEL POLYAMINE ANALOG CONJUGATES AND QUINONE CONJUGATES AS THERAPIES FOR CANCERS AND PROSTATE DISEASES
#37Pharmaceutical compounds
#38Acridine and Quinoline Derivatives as Sirtuin Modulators
#39Cancer Treatment Using Specific 3,6,9-Substituted Acridines
#40NOVEL POLYAMINE ANALOG CONJUGATES AND QUINONE CONJUGATES AS THERAPIES FOR CANCERS AND PROSTATE DISEASES
#41Aniline or phenol mustards linked to DNA-affinic molecules or water-soluble aromatic rings and their use as cancer therapeutic agents
#42Pharmaceutical compounds
#43Conformationally restricted polyamine analogs as disease therapies
#44NPY Y5 antagonist
#45Methods and compositions for treating amyloid-related diseases
#46Therapeutic acridone and acridine compounds
#47Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
#48Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
#49Absorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
#50Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
#51Perfluorinated amide salts and their uses as ionic conducting materials
#52Therapeutic acridone and acridine compounds
#53Quinones as disease therapies
#544-Aminoquinoline compounds